Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure

Hirsh, 1991, Oral anticoagulant drugs, N Engl J Med, 324, 1865, 10.1056/NEJM199106273242606 Cole, 1988, Coumarin necrosis—a review of the literature, Surgery, 103, 271 Harenberg, 2001, Cutaneous reactions to anticoagulants. Recognition and management, Am J Clin Dermatol, 2, 69, 10.2165/00128071-200102020-00003 Jorg, 2002, Anticoagulant-related skin reactions, Expert Opin Drug Saf, 1, 287, 10.1517/14740338.1.3.287 de Man, 1990, Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis, J Hepatol, 11, 318, 10.1016/0168-8278(90)90214-C den Boer, 1976, Letter: phenprocoumon-induced jaundice, Lancet, 1, 912, 10.1016/S0140-6736(76)92134-6 Ehrenforth, 1995, Phenprocoumon-induzierte nekrotisierende hepatitis, Dtsch Med Wochenschr, 120, 1529 Ehrenforth, 1999, Liver damage induced by coumarin anticoagulants, Semin Thromb Hemost, 25, 79, 10.1055/s-2007-996428 Ghosh, 1997, Coumarin-induced hepatic necrosis, Am J Gastroenterol, 92, 348 Gondocs, 1990, Syncumar induced toxic liver damage, Orv Hetil, 131, 1477 Matsukawa, 1994, Thrombosed St. Jude medical prosthesis with drug induced hepatitis due to warfarin potassium—a case report, Nippon Kyobu Geka Gakkai Zasshi, 42, 413 Hautekeete, 1995, Cytolytic hepatitis related to the oral anticoagulant phenprocoumon, Gastroenterol Clin Biol, 19, 223 Woolley, 1995, Phenprocoumon-induzierte cholestatische hepatitis, Dtsch Med Wochenschr, 120, 1507, 10.1055/s-2008-1055506 Wuillemin, 1997, Phenprocoumon-induced hepatitis delaying precise diagnosis in a thrombophilic patient with activated protein C resistance due to factor V R506Q mutation, Am J Med, 103, 437, 10.1016/S0002-9343(97)00174-5 Koch, 1997, Acute cytolytic hepatitis caused by coumarin. 2 cases, Gastroenterol Clin Biol, 21, 223 Bamanikar, 2002, Hepatotoxic reaction to warfarin in a recovering hepatitis patient with hypoalbuminenia, J Assoc Physicians India, 50, 1456 Bux-Gewehr, 2000, Phenprocoumon-induced hepatitis in a patient with a combined hereditary hemostatic disorder, Thromb Haemost, 83, 799, 10.1055/s-0037-1613920 Capoferri, 2000, Akute nekrotisierende Hepatitis: eine ungewohnliche Nebenwirkung oraler Antikoagulantien, Schweiz Rundsch Med Prax, 89, 929 Cohen, 1979, Critical review of the toxicology of coumarin with special reference to interspecies differences in metabolism and hepatotoxic response and their significance to man, Food Cosmet Toxicol, 17, 277, 10.1016/0015-6264(79)90289-X de Man, 1993, Phenprocoumon-induced liver failure, Neth J Med, 43, 91 Hinrichsen, 2001, Idiosyncratic drug allergic phenprocoumon-induced hepatitis with subacute liver failure initially misdiagnosed as autoimmune hepatitis, Scand J Gastroenterol, 36, 780, 10.1080/003655201300192076 Hohler, 1994, Drug-induced hepatitis: a rare complication of oral anticoagulants, J Hepatol, 21, 447, 10.1016/S0168-8278(05)80326-5 Kreiter, 1967, Ein Fall von Leberschadigung nach Cumarin-Medikation, Med Klin, 62, 12 Kremer Hovinga, 1999, Ein Fall von Leberschadigung nach Cumarin-Medikation, Ther Umsch, 56, 513, 10.1024/0040-5930.56.9.513 Loprinzi, 1997, Coumarin-induced hepatotoxicity, J Clin Oncol, 15, 3167, 10.1200/JCO.1997.15.9.3167 Mix, 1999, Subacute liver failure induced by phenprocoumon treatment, Digestion, 60, 579, 10.1159/000007710 Neef, 2003, Acenocoumarol is not a safe alternative for anticoagulation in phenprocoumon-induced hepatic failure. Report of two cases, Digestion, 67, 100, 10.1159/000070397 Quintana, 1997, Cholestatic hepatitis secondary to the use of acenocoumarin, Haematologica, 82, 732 Rehnqvist, 1978, Intrahepatic jaundice due to warfarin therapy, Acta Med Scand, 204, 335, 10.1111/j.0954-6820.1978.tb08449.x Renschler, 1963, Research on the effects of long-term anticoagulant therapy on the liver, Dtsch Arch Klin Med, 208, 524 Schneider, 2001, Phenprocoumon-assoziierte nekrotisierende hepatitis, Dtsch Med Wochenschr, 126, 457, 10.1055/s-2001-12889 Slagboom, 1980, Coumarin-associated hepatitis. Report of two cases, Arch Intern Med, 140, 1028, 10.1001/archinte.1980.00330190040016 Tanaka, 1985, Toxic hepatitis induced by cardiovascular agents, Nippon Rinsho, 43, 1172 Weber, 2001, Phenprocoumon-assoziierte nekrotisierende hepatitis, Dtsch Med Wochenschr, 126, 1060, 10.1055/s-2001-17308 Zaidenstein, 2002, Adverse drug events in hospitalized patients treated with cardiovascular drugs and anticoagulants, Pharmacoepidemiol Drug Saf, 11, 235, 10.1002/pds.693 Ciorciaro, 1996, Leberschaden durch Coumarin-Antikoagulantien: Erfahrungen der IKS und der SANZ, Schweiz Med Wochenschr, 126, 2109 Castedal, 1998, Fulminant hepatic failure associated with dicoumarol therapy, Liver, 18, 67, 10.1111/j.1600-0676.1998.tb00129.x Edwards, 2000, Adverse drug reactions: definitions, diagnosis, and management, Lancet, 356, 1255, 10.1016/S0140-6736(00)02799-9 Aithal, 2000, Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions, J Hepatol, 33, 949, 10.1016/S0168-8278(00)80127-0 Cordes, 2003, Phenprocoumon-induziertes Leberversagen, Dtsch Med Wochenschr, 128, 1884, 10.1055/s-2003-42161 Bassett, 1995, Liver failure while taking coumarin, Med J Aust, 163, 106, 10.5694/j.1326-5377.1995.tb126130.x Hagley, 1993, Hepatotoxicity associated with angiotensin-converting enzyme inhibitors, Ann Pharmacother, 27, 228, 10.1177/106002809302700220 Gonzalez de la Puente, 2001, Fatal hepatotoxicity associated with enalapril, Ann Pharmacother, 35, 1492, 10.1345/aph.1A055 Jeserich, 2000, Acute liver failure due to enalapril, Herz, 25, 689, 10.1007/PL00001983 de Vries, 1988, Biliary excretion of phenprocoumon and metabolites, Eur J Clin Pharmacol, 35, 433, 10.1007/BF00561379 Heimark, 1987, The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans, Clin Pharmacol Ther, 42, 312, 10.1038/clpt.1987.154 Lee, 1995, Drug-induced hepatotoxicity, N Engl J Med, 333, 1118, 10.1056/NEJM199510263331706 Lee, 2003, Drug-induced hepatotoxicity, N Engl J Med, 349, 474, 10.1056/NEJMra021844 Lake, 2002, Studies on the disposition, metabolism and hepatotoxicity of coumarin in the rat and Syrian hamster, Food Chem Toxicol, 40, 809, 10.1016/S0278-6915(02)00036-4 Schmeck-Lindau, 2003, Safety aspects of a coumarin-troxerutin combination regarding liver function in a double-blind placebo-controlled study, Int J Clin Pharmacol, 41, 193, 10.5414/CPP41193 Schwabe, 2003